STT3A , C1orf24 , TFF3 : Putative Markers for Characterization of Follicular Thyroid Neoplasms From Fine-Needle Aspirates
- 25 April 2011
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 121 (5), 983-989
- https://doi.org/10.1002/lary.21736
Abstract
Objectives/Hypothesis: The goals of this study were to characterize gene expression using fine‐needle aspirates (FNAs) from follicular neoplasms to distinguish follicular adenomas (FAs) from follicular thyroid carcinomas (FTCs) and follicular variant of papillary thyroid carcinomas (FVPTCs); and to use FNA material to distinguish benign from malignant follicular neoplasms. Study Design: Retrospective expression analysis of diagnosed follicular neoplasms (level of evidence 2b); prospective cohort of FNA from the operating room after thyroid lobectomy (level of evidence 1b). Methods: Gene expression analysis via reverse‐transcription polymerase chain reaction (rt‐PCR) of nine genes previously noted to be differentially expressed in follicular neoplasms was performed on formalin‐fixed, paraffin‐embedded archived normal thyroid tissue (n = 63) and follicular neoplasms as diagnosed on preoperative FNA: FA (n = 16), FTC (n = 13), FVPTC (n = 24), and papillary thyroid carcinomas (PTCs) (n = 10). All cases were originally read as follicular neoplasms on preoperative FNA. To determine if these results could be translated into fresh tissue, ex vivo FNA was performed on follicular neoplasms (n = 17) in the operating room after thyroidectomy. Results: Quantitative gene analysis detected differential TFF3 expression in FA versus FTC, FVPTC, and PTC (P = .02). Rt‐PCR of FNA samples demonstrated that malignant nodules overexpress STT3A as compared with benign disease (P = .046). The combination of STT3A overexpression/Clorf24 underexpression identified malignant disease (P = .03) on FNA samples. Conclusions: Gene‐expression data suggest a difference in expression between STT3A, Clorf24, and TFF3 in FAs versus carcinomas that may be detected from an FNA sample. Findings must be validated from preoperative FNAs in larger numbers.Keywords
This publication has 19 references indexed in Scilit:
- Fine‐needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow‐up according to National Cancer Institute (NCI) recommendationsDiagnostic Cytopathology, 2010
- Evaluation of the thyroid nodulePublished by Oxford University Press (OUP) ,2009
- Can cytology accurately predict benign follicular nodules?The American Journal of Surgery, 2005
- Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene CombinationJournal of Clinical Endocrinology & Metabolism, 2005
- Assessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid based cytology mediumJournal of Virological Methods, 2004
- Discrimination of Benign and Malignant Thyroid Nodules by Molecular ProfilingAnnals of Surgery, 2004
- Fine-needle aspiration in PreservCyt®: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOFLaboratory Investigation, 2004
- A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expressionJCI Insight, 2004
- ThinPrep®-processed fine-needle samples of breast are effective material for RNA- and DNA-based molecular diagnosisCancer, 2003
- Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titrationProceedings of the National Academy of Sciences of the United States of America, 2002